Two Sigma Investments’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-575,111
| Closed | -$11.6M | – | 3312 |
|
|
2021
Q3 | $11.6M | Buy |
575,111
+294,355
| +105% | +$5.93M | 0.03% | 551 |
|
|
2021
Q2 | $10.5M | Buy |
+280,756
| New | +$10.5M | 0.02% | 631 |
|
|
2021
Q1 | – | Sell |
-14,091
| Closed | -$310K | – | 2825 |
|
|
2020
Q4 | $310K | Sell |
14,091
-122,908
| -90% | -$2.7M | ﹤0.01% | 1723 |
|
|
2020
Q3 | $2.47M | Sell |
136,999
-130,244
| -49% | -$2.34M | 0.01% | 844 |
|
|
2020
Q2 | $6.79M | Sell |
267,243
-56,225
| -17% | -$1.43M | 0.03% | 436 |
|
|
2020
Q1 | $5.94M | Sell |
323,468
-234,139
| -42% | -$4.3M | 0.05% | 338 |
|
|
2019
Q4 | $12.3M | Buy |
+557,607
| New | +$12.3M | 0.04% | 457 |
|
|
2019
Q3 | – | Sell |
-52,379
| Closed | -$825K | – | 2493 |
|
|
2019
Q2 | $825K | Buy |
+52,379
| New | +$825K | ﹤0.01% | 1425 |
|
|
2019
Q1 | – | Sell |
-116,152
| Closed | -$1.24M | – | 2548 |
|
|
2018
Q4 | $1.24M | Buy |
116,152
+34,433
| +42% | +$368K | ﹤0.01% | 1224 |
|
|
2018
Q3 | $1.25M | Sell |
81,719
-19,312
| -19% | -$295K | ﹤0.01% | 1280 |
|
|
2018
Q2 | $1.24M | Buy |
101,031
+38,254
| +61% | +$469K | ﹤0.01% | 1276 |
|
|
2018
Q1 | $600K | Buy |
+62,777
| New | +$600K | ﹤0.01% | 1511 |
|
|
2016
Q3 | – | Sell |
-30,134
| Closed | -$90K | – | 2382 |
|
|
2016
Q2 | $90K | Buy |
+30,134
| New | +$90K | ﹤0.01% | 1944 |
|